Hempfusion Wellness Inc.
Hempfusion Wellness Inc. (CBDHF) Stock Competitors & Peer Comparison
See (CBDHF) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| CBDHF | $0.00 | +0.00% | 1.6K | N/A | -$0.04 | N/A |
| IPSEY | $48.21 | +9.55% | 61.2B | 30.06 | $1.54 | +0.86% |
| MKKGY | $25.35 | +4.04% | 54.8B | 18.12 | $1.39 | +2.00% |
| TKPHF | $34.52 | +0.00% | 54.5B | 78.45 | $0.44 | +3.39% |
| MKGAF | $123.87 | -3.05% | 53.2B | 17.63 | $6.94 | +2.04% |
| HLNCF | $4.93 | +0.20% | 44.3B | 19.92 | $0.25 | +1.84% |
| SDZNY | $80.86 | +6.98% | 33.8B | 37.35 | $2.09 | +0.94% |
| TEVJF | $28.36 | +0.00% | 32.5B | 23.44 | $1.21 | N/A |
| SGIOF | $23.60 | +10.02% | 20.1B | 18.73 | $1.26 | +1.64% |
| SGIOY | $11.37 | +4.58% | 18.8B | 17.51 | $0.63 | +1.82% |
Stock Comparison
CBDHF vs IPSEY Comparison April 2026
CBDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBDHF stands at 1.6K. In comparison, IPSEY has a market cap of 61.2B. Regarding current trading prices, CBDHF is priced at $0.00, while IPSEY trades at $48.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBDHF currently has a P/E ratio of N/A, whereas IPSEY's P/E ratio is 30.06. In terms of profitability, CBDHF's ROE is +0.00%, compared to IPSEY's ROE of +0.10%. Regarding short-term risk, CBDHF is more volatile compared to IPSEY. This indicates potentially higher risk in terms of short-term price fluctuations for CBDHF.Check IPSEY's competition here
CBDHF vs MKKGY Comparison April 2026
CBDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBDHF stands at 1.6K. In comparison, MKKGY has a market cap of 54.8B. Regarding current trading prices, CBDHF is priced at $0.00, while MKKGY trades at $25.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBDHF currently has a P/E ratio of N/A, whereas MKKGY's P/E ratio is 18.12. In terms of profitability, CBDHF's ROE is +0.00%, compared to MKKGY's ROE of +0.09%. Regarding short-term risk, CBDHF is more volatile compared to MKKGY. This indicates potentially higher risk in terms of short-term price fluctuations for CBDHF.Check MKKGY's competition here
CBDHF vs TKPHF Comparison April 2026
CBDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBDHF stands at 1.6K. In comparison, TKPHF has a market cap of 54.5B. Regarding current trading prices, CBDHF is priced at $0.00, while TKPHF trades at $34.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBDHF currently has a P/E ratio of N/A, whereas TKPHF's P/E ratio is 78.45. In terms of profitability, CBDHF's ROE is +0.00%, compared to TKPHF's ROE of +0.02%. Regarding short-term risk, CBDHF is more volatile compared to TKPHF. This indicates potentially higher risk in terms of short-term price fluctuations for CBDHF.Check TKPHF's competition here
CBDHF vs MKGAF Comparison April 2026
CBDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBDHF stands at 1.6K. In comparison, MKGAF has a market cap of 53.2B. Regarding current trading prices, CBDHF is priced at $0.00, while MKGAF trades at $123.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBDHF currently has a P/E ratio of N/A, whereas MKGAF's P/E ratio is 17.63. In terms of profitability, CBDHF's ROE is +0.00%, compared to MKGAF's ROE of +0.09%. Regarding short-term risk, CBDHF is more volatile compared to MKGAF. This indicates potentially higher risk in terms of short-term price fluctuations for CBDHF.Check MKGAF's competition here
CBDHF vs HLNCF Comparison April 2026
CBDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBDHF stands at 1.6K. In comparison, HLNCF has a market cap of 44.3B. Regarding current trading prices, CBDHF is priced at $0.00, while HLNCF trades at $4.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBDHF currently has a P/E ratio of N/A, whereas HLNCF's P/E ratio is 19.92. In terms of profitability, CBDHF's ROE is +0.00%, compared to HLNCF's ROE of +0.06%. Regarding short-term risk, CBDHF is more volatile compared to HLNCF. This indicates potentially higher risk in terms of short-term price fluctuations for CBDHF.Check HLNCF's competition here
CBDHF vs SDZNY Comparison April 2026
CBDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBDHF stands at 1.6K. In comparison, SDZNY has a market cap of 33.8B. Regarding current trading prices, CBDHF is priced at $0.00, while SDZNY trades at $80.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBDHF currently has a P/E ratio of N/A, whereas SDZNY's P/E ratio is 37.35. In terms of profitability, CBDHF's ROE is +0.00%, compared to SDZNY's ROE of +0.08%. Regarding short-term risk, CBDHF is more volatile compared to SDZNY. This indicates potentially higher risk in terms of short-term price fluctuations for CBDHF.Check SDZNY's competition here
CBDHF vs TEVJF Comparison April 2026
CBDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBDHF stands at 1.6K. In comparison, TEVJF has a market cap of 32.5B. Regarding current trading prices, CBDHF is priced at $0.00, while TEVJF trades at $28.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBDHF currently has a P/E ratio of N/A, whereas TEVJF's P/E ratio is 23.44. In terms of profitability, CBDHF's ROE is +0.00%, compared to TEVJF's ROE of +0.20%. Regarding short-term risk, CBDHF is more volatile compared to TEVJF. This indicates potentially higher risk in terms of short-term price fluctuations for CBDHF.Check TEVJF's competition here
CBDHF vs SGIOF Comparison April 2026
CBDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBDHF stands at 1.6K. In comparison, SGIOF has a market cap of 20.1B. Regarding current trading prices, CBDHF is priced at $0.00, while SGIOF trades at $23.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBDHF currently has a P/E ratio of N/A, whereas SGIOF's P/E ratio is 18.73. In terms of profitability, CBDHF's ROE is +0.00%, compared to SGIOF's ROE of +0.14%. Regarding short-term risk, CBDHF is more volatile compared to SGIOF. This indicates potentially higher risk in terms of short-term price fluctuations for CBDHF.Check SGIOF's competition here
CBDHF vs SGIOY Comparison April 2026
CBDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBDHF stands at 1.6K. In comparison, SGIOY has a market cap of 18.8B. Regarding current trading prices, CBDHF is priced at $0.00, while SGIOY trades at $11.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBDHF currently has a P/E ratio of N/A, whereas SGIOY's P/E ratio is 17.51. In terms of profitability, CBDHF's ROE is +0.00%, compared to SGIOY's ROE of +0.14%. Regarding short-term risk, CBDHF is more volatile compared to SGIOY. This indicates potentially higher risk in terms of short-term price fluctuations for CBDHF.Check SGIOY's competition here
CBDHF vs TAIPY Comparison April 2026
CBDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBDHF stands at 1.6K. In comparison, TAIPY has a market cap of 18.1B. Regarding current trading prices, CBDHF is priced at $0.00, while TAIPY trades at $14.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBDHF currently has a P/E ratio of N/A, whereas TAIPY's P/E ratio is 82.35. In terms of profitability, CBDHF's ROE is +0.00%, compared to TAIPY's ROE of +0.02%. Regarding short-term risk, CBDHF is more volatile compared to TAIPY. This indicates potentially higher risk in terms of short-term price fluctuations for CBDHF.Check TAIPY's competition here
CBDHF vs ESALY Comparison April 2026
CBDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBDHF stands at 1.6K. In comparison, ESALY has a market cap of 17.6B. Regarding current trading prices, CBDHF is priced at $0.00, while ESALY trades at $61.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBDHF currently has a P/E ratio of N/A, whereas ESALY's P/E ratio is 20.54. In terms of profitability, CBDHF's ROE is +0.00%, compared to ESALY's ROE of +0.06%. Regarding short-term risk, CBDHF is more volatile compared to ESALY. This indicates potentially higher risk in terms of short-term price fluctuations for CBDHF.Check ESALY's competition here
CBDHF vs BIOVF Comparison April 2026
CBDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBDHF stands at 1.6K. In comparison, BIOVF has a market cap of 13.8B. Regarding current trading prices, CBDHF is priced at $0.00, while BIOVF trades at $39.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBDHF currently has a P/E ratio of N/A, whereas BIOVF's P/E ratio is 284.79. In terms of profitability, CBDHF's ROE is +0.00%, compared to BIOVF's ROE of +0.01%. Regarding short-term risk, CBDHF is more volatile compared to BIOVF. This indicates potentially higher risk in terms of short-term price fluctuations for CBDHF.Check BIOVF's competition here
CBDHF vs IPSEF Comparison April 2026
CBDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBDHF stands at 1.6K. In comparison, IPSEF has a market cap of 9.4B. Regarding current trading prices, CBDHF is priced at $0.00, while IPSEF trades at $113.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBDHF currently has a P/E ratio of N/A, whereas IPSEF's P/E ratio is 18.07. In terms of profitability, CBDHF's ROE is +0.00%, compared to IPSEF's ROE of +0.12%. Regarding short-term risk, CBDHF is more volatile compared to IPSEF. This indicates potentially higher risk in terms of short-term price fluctuations for CBDHF.Check IPSEF's competition here
CBDHF vs ESAIY Comparison April 2026
CBDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBDHF stands at 1.6K. In comparison, ESAIY has a market cap of 8.9B. Regarding current trading prices, CBDHF is priced at $0.00, while ESAIY trades at $8.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBDHF currently has a P/E ratio of N/A, whereas ESAIY's P/E ratio is 28.81. In terms of profitability, CBDHF's ROE is +0.00%, compared to ESAIY's ROE of +0.05%. Regarding short-term risk, CBDHF is more volatile compared to ESAIY. This indicates potentially higher risk in terms of short-term price fluctuations for CBDHF.Check ESAIY's competition here
CBDHF vs ESALF Comparison April 2026
CBDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBDHF stands at 1.6K. In comparison, ESALF has a market cap of 8.5B. Regarding current trading prices, CBDHF is priced at $0.00, while ESALF trades at $30.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBDHF currently has a P/E ratio of N/A, whereas ESALF's P/E ratio is 27.27. In terms of profitability, CBDHF's ROE is +0.00%, compared to ESALF's ROE of +0.05%. Regarding short-term risk, CBDHF is more volatile compared to ESALF. This indicates potentially higher risk in terms of short-term price fluctuations for CBDHF.Check ESALF's competition here
CBDHF vs SFOSF Comparison April 2026
CBDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBDHF stands at 1.6K. In comparison, SFOSF has a market cap of 7.1B. Regarding current trading prices, CBDHF is priced at $0.00, while SFOSF trades at $2.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBDHF currently has a P/E ratio of N/A, whereas SFOSF's P/E ratio is 15.00. In terms of profitability, CBDHF's ROE is +0.00%, compared to SFOSF's ROE of +0.09%. Regarding short-term risk, CBDHF is more volatile compared to SFOSF. This indicates potentially higher risk in terms of short-term price fluctuations for CBDHF.Check SFOSF's competition here
CBDHF vs GZPHF Comparison April 2026
CBDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBDHF stands at 1.6K. In comparison, GZPHF has a market cap of 6.2B. Regarding current trading prices, CBDHF is priced at $0.00, while GZPHF trades at $2.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBDHF currently has a P/E ratio of N/A, whereas GZPHF's P/E ratio is 9.00. In terms of profitability, CBDHF's ROE is +0.00%, compared to GZPHF's ROE of +0.08%. Regarding short-term risk, CBDHF is more volatile compared to GZPHF. This indicates potentially higher risk in terms of short-term price fluctuations for CBDHF.Check GZPHF's competition here
CBDHF vs LVZPF Comparison April 2026
CBDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBDHF stands at 1.6K. In comparison, LVZPF has a market cap of 6.1B. Regarding current trading prices, CBDHF is priced at $0.00, while LVZPF trades at $5.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBDHF currently has a P/E ratio of N/A, whereas LVZPF's P/E ratio is 15.35. In terms of profitability, CBDHF's ROE is +0.00%, compared to LVZPF's ROE of +0.15%. Regarding short-term risk, CBDHF is more volatile compared to LVZPF. This indicates potentially higher risk in terms of short-term price fluctuations for CBDHF.Check LVZPF's competition here
CBDHF vs DNPUF Comparison April 2026
CBDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBDHF stands at 1.6K. In comparison, DNPUF has a market cap of 5.4B. Regarding current trading prices, CBDHF is priced at $0.00, while DNPUF trades at $14.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBDHF currently has a P/E ratio of N/A, whereas DNPUF's P/E ratio is 5.57. In terms of profitability, CBDHF's ROE is +0.00%, compared to DNPUF's ROE of +0.49%. Regarding short-term risk, CBDHF is more volatile compared to DNPUF. This indicates potentially higher risk in terms of short-term price fluctuations for CBDHF.Check DNPUF's competition here
CBDHF vs HLBBF Comparison April 2026
CBDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBDHF stands at 1.6K. In comparison, HLBBF has a market cap of 4.9B. Regarding current trading prices, CBDHF is priced at $0.00, while HLBBF trades at $5.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBDHF currently has a P/E ratio of N/A, whereas HLBBF's P/E ratio is 12.11. In terms of profitability, CBDHF's ROE is +0.00%, compared to HLBBF's ROE of +0.13%. Regarding short-term risk, CBDHF is more volatile compared to HLBBF. This indicates potentially higher risk in terms of short-term price fluctuations for CBDHF.Check HLBBF's competition here
CBDHF vs SMDPY Comparison April 2026
CBDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBDHF stands at 1.6K. In comparison, SMDPY has a market cap of 4.8B. Regarding current trading prices, CBDHF is priced at $0.00, while SMDPY trades at $14.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBDHF currently has a P/E ratio of N/A, whereas SMDPY's P/E ratio is 4.97. In terms of profitability, CBDHF's ROE is +0.00%, compared to SMDPY's ROE of +0.49%. Regarding short-term risk, CBDHF is more volatile compared to SMDPY. This indicates potentially higher risk in terms of short-term price fluctuations for CBDHF.Check SMDPY's competition here
CBDHF vs HLUBF Comparison April 2026
CBDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBDHF stands at 1.6K. In comparison, HLUBF has a market cap of 4.8B. Regarding current trading prices, CBDHF is priced at $0.00, while HLUBF trades at $4.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBDHF currently has a P/E ratio of N/A, whereas HLUBF's P/E ratio is 9.64. In terms of profitability, CBDHF's ROE is +0.00%, compared to HLUBF's ROE of +0.13%. Regarding short-term risk, CBDHF is more volatile compared to HLUBF. This indicates potentially higher risk in terms of short-term price fluctuations for CBDHF.Check HLUBF's competition here
CBDHF vs SGFEF Comparison April 2026
CBDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBDHF stands at 1.6K. In comparison, SGFEF has a market cap of 4.4B. Regarding current trading prices, CBDHF is priced at $0.00, while SGFEF trades at $100.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBDHF currently has a P/E ratio of N/A, whereas SGFEF's P/E ratio is 20.62. In terms of profitability, CBDHF's ROE is +0.00%, compared to SGFEF's ROE of +0.16%. Regarding short-term risk, CBDHF is less volatile compared to SGFEF. This indicates potentially lower risk in terms of short-term price fluctuations for CBDHF.Check SGFEF's competition here
CBDHF vs HKMPF Comparison April 2026
CBDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBDHF stands at 1.6K. In comparison, HKMPF has a market cap of 3.8B. Regarding current trading prices, CBDHF is priced at $0.00, while HKMPF trades at $17.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBDHF currently has a P/E ratio of N/A, whereas HKMPF's P/E ratio is 9.56. In terms of profitability, CBDHF's ROE is +0.00%, compared to HKMPF's ROE of +0.16%. Regarding short-term risk, CBDHF is more volatile compared to HKMPF. This indicates potentially higher risk in terms of short-term price fluctuations for CBDHF.Check HKMPF's competition here
CBDHF vs HKMPY Comparison April 2026
CBDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBDHF stands at 1.6K. In comparison, HKMPY has a market cap of 3.7B. Regarding current trading prices, CBDHF is priced at $0.00, while HKMPY trades at $35.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBDHF currently has a P/E ratio of N/A, whereas HKMPY's P/E ratio is 9.18. In terms of profitability, CBDHF's ROE is +0.00%, compared to HKMPY's ROE of +0.16%. Regarding short-term risk, CBDHF is more volatile compared to HKMPY. This indicates potentially higher risk in terms of short-term price fluctuations for CBDHF.Check HKMPY's competition here
CBDHF vs APNHF Comparison April 2026
CBDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBDHF stands at 1.6K. In comparison, APNHF has a market cap of 3.6B. Regarding current trading prices, CBDHF is priced at $0.00, while APNHF trades at $8.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBDHF currently has a P/E ratio of N/A, whereas APNHF's P/E ratio is -34.17. In terms of profitability, CBDHF's ROE is +0.00%, compared to APNHF's ROE of -0.02%. Regarding short-term risk, CBDHF is more volatile compared to APNHF. This indicates potentially higher risk in terms of short-term price fluctuations for CBDHF.Check APNHF's competition here
CBDHF vs APNHY Comparison April 2026
CBDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBDHF stands at 1.6K. In comparison, APNHY has a market cap of 3.5B. Regarding current trading prices, CBDHF is priced at $0.00, while APNHY trades at $7.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBDHF currently has a P/E ratio of N/A, whereas APNHY's P/E ratio is -32.37. In terms of profitability, CBDHF's ROE is +0.00%, compared to APNHY's ROE of -0.02%. Regarding short-term risk, CBDHF is more volatile compared to APNHY. This indicates potentially higher risk in terms of short-term price fluctuations for CBDHF.Check APNHY's competition here
CBDHF vs LBTSF Comparison April 2026
CBDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBDHF stands at 1.6K. In comparison, LBTSF has a market cap of 3.3B. Regarding current trading prices, CBDHF is priced at $0.00, while LBTSF trades at $15.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBDHF currently has a P/E ratio of N/A, whereas LBTSF's P/E ratio is 61.40. In terms of profitability, CBDHF's ROE is +0.00%, compared to LBTSF's ROE of +0.04%. Regarding short-term risk, CBDHF is more volatile compared to LBTSF. This indicates potentially higher risk in terms of short-term price fluctuations for CBDHF.Check LBTSF's competition here
CBDHF vs CHSYF Comparison April 2026
CBDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBDHF stands at 1.6K. In comparison, CHSYF has a market cap of 3.3B. Regarding current trading prices, CBDHF is priced at $0.00, while CHSYF trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBDHF currently has a P/E ratio of N/A, whereas CHSYF's P/E ratio is 13.50. In terms of profitability, CBDHF's ROE is +0.00%, compared to CHSYF's ROE of +0.09%. Regarding short-term risk, CBDHF is more volatile compared to CHSYF. This indicates potentially higher risk in terms of short-term price fluctuations for CBDHF.Check CHSYF's competition here
CBDHF vs INVVY Comparison April 2026
CBDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBDHF stands at 1.6K. In comparison, INVVY has a market cap of 3B. Regarding current trading prices, CBDHF is priced at $0.00, while INVVY trades at $21.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBDHF currently has a P/E ratio of N/A, whereas INVVY's P/E ratio is -62.42. In terms of profitability, CBDHF's ROE is +0.00%, compared to INVVY's ROE of -0.99%. Regarding short-term risk, CBDHF is more volatile compared to INVVY. This indicates potentially higher risk in terms of short-term price fluctuations for CBDHF.Check INVVY's competition here
CBDHF vs HYPMY Comparison April 2026
CBDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBDHF stands at 1.6K. In comparison, HYPMY has a market cap of 3B. Regarding current trading prices, CBDHF is priced at $0.00, while HYPMY trades at $4.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBDHF currently has a P/E ratio of N/A, whereas HYPMY's P/E ratio is 12.17. In terms of profitability, CBDHF's ROE is +0.00%, compared to HYPMY's ROE of +0.10%. Regarding short-term risk, CBDHF is more volatile compared to HYPMY. This indicates potentially higher risk in terms of short-term price fluctuations for CBDHF.Check HYPMY's competition here
CBDHF vs IZQVF Comparison April 2026
CBDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBDHF stands at 1.6K. In comparison, IZQVF has a market cap of 2.9B. Regarding current trading prices, CBDHF is priced at $0.00, while IZQVF trades at $20.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBDHF currently has a P/E ratio of N/A, whereas IZQVF's P/E ratio is -56.68. In terms of profitability, CBDHF's ROE is +0.00%, compared to IZQVF's ROE of -0.99%. Regarding short-term risk, CBDHF is more volatile compared to IZQVF. This indicates potentially higher risk in terms of short-term price fluctuations for CBDHF.Check IZQVF's competition here
CBDHF vs DMPHF Comparison April 2026
CBDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBDHF stands at 1.6K. In comparison, DMPHF has a market cap of 2.6B. Regarding current trading prices, CBDHF is priced at $0.00, while DMPHF trades at $48.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBDHF currently has a P/E ratio of N/A, whereas DMPHF's P/E ratio is 21.99. In terms of profitability, CBDHF's ROE is +0.00%, compared to DMPHF's ROE of +0.19%. Regarding short-term risk, CBDHF is more volatile compared to DMPHF. This indicates potentially higher risk in terms of short-term price fluctuations for CBDHF.Check DMPHF's competition here
CBDHF vs ULIHF Comparison April 2026
CBDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBDHF stands at 1.6K. In comparison, ULIHF has a market cap of 2.6B. Regarding current trading prices, CBDHF is priced at $0.00, while ULIHF trades at $1.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBDHF currently has a P/E ratio of N/A, whereas ULIHF's P/E ratio is 8.13. In terms of profitability, CBDHF's ROE is +0.00%, compared to ULIHF's ROE of +0.13%. Regarding short-term risk, CBDHF is more volatile compared to ULIHF. This indicates potentially higher risk in terms of short-term price fluctuations for CBDHF.Check ULIHF's competition here
CBDHF vs HMDCF Comparison April 2026
CBDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBDHF stands at 1.6K. In comparison, HMDCF has a market cap of 2.4B. Regarding current trading prices, CBDHF is priced at $0.00, while HMDCF trades at $2.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBDHF currently has a P/E ratio of N/A, whereas HMDCF's P/E ratio is 5.32. In terms of profitability, CBDHF's ROE is +0.00%, compared to HMDCF's ROE of +0.41%. Regarding short-term risk, CBDHF is more volatile compared to HMDCF. This indicates potentially higher risk in terms of short-term price fluctuations for CBDHF.Check HMDCF's competition here
CBDHF vs NPNKF Comparison April 2026
CBDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBDHF stands at 1.6K. In comparison, NPNKF has a market cap of 2.2B. Regarding current trading prices, CBDHF is priced at $0.00, while NPNKF trades at $32.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBDHF currently has a P/E ratio of N/A, whereas NPNKF's P/E ratio is 10.77. In terms of profitability, CBDHF's ROE is +0.00%, compared to NPNKF's ROE of +0.11%. Regarding short-term risk, CBDHF is more volatile compared to NPNKF. This indicates potentially higher risk in terms of short-term price fluctuations for CBDHF.Check NPNKF's competition here
CBDHF vs HTSUF Comparison April 2026
CBDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBDHF stands at 1.6K. In comparison, HTSUF has a market cap of 2B. Regarding current trading prices, CBDHF is priced at $0.00, while HTSUF trades at $29.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBDHF currently has a P/E ratio of N/A, whereas HTSUF's P/E ratio is 16.76. In terms of profitability, CBDHF's ROE is +0.00%, compared to HTSUF's ROE of +0.07%. Regarding short-term risk, CBDHF is more volatile compared to HTSUF. This indicates potentially higher risk in terms of short-term price fluctuations for CBDHF.Check HTSUF's competition here
CBDHF vs NPPNY Comparison April 2026
CBDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBDHF stands at 1.6K. In comparison, NPPNY has a market cap of 2B. Regarding current trading prices, CBDHF is priced at $0.00, while NPPNY trades at $7.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBDHF currently has a P/E ratio of N/A, whereas NPPNY's P/E ratio is 10.00. In terms of profitability, CBDHF's ROE is +0.00%, compared to NPPNY's ROE of +0.12%. Regarding short-term risk, CBDHF is more volatile compared to NPPNY. This indicates potentially higher risk in terms of short-term price fluctuations for CBDHF.Check NPPNY's competition here
CBDHF vs ARSUF Comparison April 2026
CBDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBDHF stands at 1.6K. In comparison, ARSUF has a market cap of 2B. Regarding current trading prices, CBDHF is priced at $0.00, while ARSUF trades at $27.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBDHF currently has a P/E ratio of N/A, whereas ARSUF's P/E ratio is 18.88. In terms of profitability, CBDHF's ROE is +0.00%, compared to ARSUF's ROE of +0.17%. Regarding short-term risk, CBDHF is more volatile compared to ARSUF. This indicates potentially higher risk in terms of short-term price fluctuations for CBDHF.Check ARSUF's competition here
CBDHF vs DUTV Comparison April 2026
CBDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBDHF stands at 1.6K. In comparison, DUTV has a market cap of 1.9B. Regarding current trading prices, CBDHF is priced at $0.00, while DUTV trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBDHF currently has a P/E ratio of N/A, whereas DUTV's P/E ratio is N/A. In terms of profitability, CBDHF's ROE is +0.00%, compared to DUTV's ROE of -0.04%. Regarding short-term risk, CBDHF is more volatile compared to DUTV. This indicates potentially higher risk in terms of short-term price fluctuations for CBDHF.Check DUTV's competition here
CBDHF vs TSMRF Comparison April 2026
CBDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBDHF stands at 1.6K. In comparison, TSMRF has a market cap of 1.7B. Regarding current trading prices, CBDHF is priced at $0.00, while TSMRF trades at $23.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBDHF currently has a P/E ratio of N/A, whereas TSMRF's P/E ratio is 10.04. In terms of profitability, CBDHF's ROE is +0.00%, compared to TSMRF's ROE of +0.10%. Regarding short-term risk, CBDHF is more volatile compared to TSMRF. This indicates potentially higher risk in terms of short-term price fluctuations for CBDHF.Check TSMRF's competition here
CBDHF vs SHPHF Comparison April 2026
CBDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBDHF stands at 1.6K. In comparison, SHPHF has a market cap of 1.7B. Regarding current trading prices, CBDHF is priced at $0.00, while SHPHF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBDHF currently has a P/E ratio of N/A, whereas SHPHF's P/E ratio is -6.22. In terms of profitability, CBDHF's ROE is +0.00%, compared to SHPHF's ROE of -0.02%. Regarding short-term risk, CBDHF is more volatile compared to SHPHF. This indicates potentially higher risk in terms of short-term price fluctuations for CBDHF.Check SHPHF's competition here
CBDHF vs CURLF Comparison April 2026
CBDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBDHF stands at 1.6K. In comparison, CURLF has a market cap of 1.7B. Regarding current trading prices, CBDHF is priced at $0.00, while CURLF trades at $2.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBDHF currently has a P/E ratio of N/A, whereas CURLF's P/E ratio is -6.72. In terms of profitability, CBDHF's ROE is +0.00%, compared to CURLF's ROE of -0.29%. Regarding short-term risk, CBDHF is more volatile compared to CURLF. This indicates potentially higher risk in terms of short-term price fluctuations for CBDHF.Check CURLF's competition here
CBDHF vs MITPF Comparison April 2026
CBDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBDHF stands at 1.6K. In comparison, MITPF has a market cap of 1.6B. Regarding current trading prices, CBDHF is priced at $0.00, while MITPF trades at $23.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBDHF currently has a P/E ratio of N/A, whereas MITPF's P/E ratio is -10.81. In terms of profitability, CBDHF's ROE is +0.00%, compared to MITPF's ROE of +4.99%. Regarding short-term risk, CBDHF is more volatile compared to MITPF. This indicates potentially higher risk in terms of short-term price fluctuations for CBDHF.Check MITPF's competition here
CBDHF vs KARBF Comparison April 2026
CBDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBDHF stands at 1.6K. In comparison, KARBF has a market cap of 1.5B. Regarding current trading prices, CBDHF is priced at $0.00, while KARBF trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBDHF currently has a P/E ratio of N/A, whereas KARBF's P/E ratio is 262.50. In terms of profitability, CBDHF's ROE is +0.00%, compared to KARBF's ROE of N/A. Regarding short-term risk, CBDHF is more volatile compared to KARBF. This indicates potentially higher risk in terms of short-term price fluctuations for CBDHF.Check KARBF's competition here
CBDHF vs GTBIF Comparison April 2026
CBDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBDHF stands at 1.6K. In comparison, GTBIF has a market cap of 1.5B. Regarding current trading prices, CBDHF is priced at $0.00, while GTBIF trades at $6.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBDHF currently has a P/E ratio of N/A, whereas GTBIF's P/E ratio is 13.23. In terms of profitability, CBDHF's ROE is +0.00%, compared to GTBIF's ROE of +0.06%. Regarding short-term risk, CBDHF is more volatile compared to GTBIF. This indicates potentially higher risk in terms of short-term price fluctuations for CBDHF.Check GTBIF's competition here
CBDHF vs CHIZF Comparison April 2026
CBDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBDHF stands at 1.6K. In comparison, CHIZF has a market cap of 1.4B. Regarding current trading prices, CBDHF is priced at $0.00, while CHIZF trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBDHF currently has a P/E ratio of N/A, whereas CHIZF's P/E ratio is -27.34. In terms of profitability, CBDHF's ROE is +0.00%, compared to CHIZF's ROE of -0.01%. Regarding short-term risk, CBDHF is more volatile compared to CHIZF. This indicates potentially higher risk in terms of short-term price fluctuations for CBDHF.Check CHIZF's competition here
CBDHF vs CASBF Comparison April 2026
CBDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBDHF stands at 1.6K. In comparison, CASBF has a market cap of 1.3B. Regarding current trading prices, CBDHF is priced at $0.00, while CASBF trades at $3.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBDHF currently has a P/E ratio of N/A, whereas CASBF's P/E ratio is -38.60. In terms of profitability, CBDHF's ROE is +0.00%, compared to CASBF's ROE of +0.01%. Regarding short-term risk, CBDHF is more volatile compared to CASBF. This indicates potentially higher risk in terms of short-term price fluctuations for CBDHF.Check CASBF's competition here
CBDHF vs SWGHF Comparison April 2026
CBDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBDHF stands at 1.6K. In comparison, SWGHF has a market cap of 1.3B. Regarding current trading prices, CBDHF is priced at $0.00, while SWGHF trades at $11.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBDHF currently has a P/E ratio of N/A, whereas SWGHF's P/E ratio is 15.57. In terms of profitability, CBDHF's ROE is +0.00%, compared to SWGHF's ROE of +0.05%. Regarding short-term risk, CBDHF is more volatile compared to SWGHF. This indicates potentially higher risk in terms of short-term price fluctuations for CBDHF.Check SWGHF's competition here
CBDHF vs LJUIF Comparison April 2026
CBDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBDHF stands at 1.6K. In comparison, LJUIF has a market cap of 1.2B. Regarding current trading prices, CBDHF is priced at $0.00, while LJUIF trades at $0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBDHF currently has a P/E ratio of N/A, whereas LJUIF's P/E ratio is 13.42. In terms of profitability, CBDHF's ROE is +0.00%, compared to LJUIF's ROE of +0.06%. Regarding short-term risk, CBDHF is more volatile compared to LJUIF. This indicates potentially higher risk in terms of short-term price fluctuations for CBDHF.Check LJUIF's competition here
CBDHF vs TCNNF Comparison April 2026
CBDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBDHF stands at 1.6K. In comparison, TCNNF has a market cap of 1.1B. Regarding current trading prices, CBDHF is priced at $0.00, while TCNNF trades at $5.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBDHF currently has a P/E ratio of N/A, whereas TCNNF's P/E ratio is -9.75. In terms of profitability, CBDHF's ROE is +0.00%, compared to TCNNF's ROE of -0.10%. Regarding short-term risk, CBDHF is more volatile compared to TCNNF. This indicates potentially higher risk in terms of short-term price fluctuations for CBDHF.Check TCNNF's competition here
CBDHF vs BIOGY Comparison April 2026
CBDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBDHF stands at 1.6K. In comparison, BIOGY has a market cap of 1.1B. Regarding current trading prices, CBDHF is priced at $0.00, while BIOGY trades at $11.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBDHF currently has a P/E ratio of N/A, whereas BIOGY's P/E ratio is 31.43. In terms of profitability, CBDHF's ROE is +0.00%, compared to BIOGY's ROE of +0.24%. Regarding short-term risk, CBDHF is more volatile compared to BIOGY. This indicates potentially higher risk in terms of short-term price fluctuations for CBDHF.Check BIOGY's competition here
CBDHF vs KSPHF Comparison April 2026
CBDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBDHF stands at 1.6K. In comparison, KSPHF has a market cap of 1.1B. Regarding current trading prices, CBDHF is priced at $0.00, while KSPHF trades at $25.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBDHF currently has a P/E ratio of N/A, whereas KSPHF's P/E ratio is 11.99. In terms of profitability, CBDHF's ROE is +0.00%, compared to KSPHF's ROE of +0.07%. Regarding short-term risk, CBDHF is more volatile compared to KSPHF. This indicates potentially higher risk in terms of short-term price fluctuations for CBDHF.Check KSPHF's competition here
CBDHF vs KKPCF Comparison April 2026
CBDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBDHF stands at 1.6K. In comparison, KKPCF has a market cap of 984.6M. Regarding current trading prices, CBDHF is priced at $0.00, while KKPCF trades at $26.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBDHF currently has a P/E ratio of N/A, whereas KKPCF's P/E ratio is 288.89. In terms of profitability, CBDHF's ROE is +0.00%, compared to KKPCF's ROE of -0.03%. Regarding short-term risk, CBDHF is more volatile compared to KKPCF. This indicates potentially higher risk in terms of short-term price fluctuations for CBDHF.Check KKPCF's competition here
CBDHF vs EVOTF Comparison April 2026
CBDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBDHF stands at 1.6K. In comparison, EVOTF has a market cap of 931.2M. Regarding current trading prices, CBDHF is priced at $0.00, while EVOTF trades at $5.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBDHF currently has a P/E ratio of N/A, whereas EVOTF's P/E ratio is -5.04. In terms of profitability, CBDHF's ROE is +0.00%, compared to EVOTF's ROE of -0.18%. Regarding short-term risk, CBDHF is more volatile compared to EVOTF. This indicates potentially higher risk in terms of short-term price fluctuations for CBDHF.Check EVOTF's competition here
CBDHF vs GNMLF Comparison April 2026
CBDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBDHF stands at 1.6K. In comparison, GNMLF has a market cap of 886.9M. Regarding current trading prices, CBDHF is priced at $0.00, while GNMLF trades at $0.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBDHF currently has a P/E ratio of N/A, whereas GNMLF's P/E ratio is 10.12. In terms of profitability, CBDHF's ROE is +0.00%, compared to GNMLF's ROE of +0.11%. Regarding short-term risk, CBDHF is more volatile compared to GNMLF. This indicates potentially higher risk in terms of short-term price fluctuations for CBDHF.Check GNMLF's competition here
CBDHF vs TWAPF Comparison April 2026
CBDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBDHF stands at 1.6K. In comparison, TWAPF has a market cap of 828.5M. Regarding current trading prices, CBDHF is priced at $0.00, while TWAPF trades at $16.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBDHF currently has a P/E ratio of N/A, whereas TWAPF's P/E ratio is 6.28. In terms of profitability, CBDHF's ROE is +0.00%, compared to TWAPF's ROE of +0.12%. Regarding short-term risk, CBDHF is more volatile compared to TWAPF. This indicates potentially higher risk in terms of short-term price fluctuations for CBDHF.Check TWAPF's competition here
CBDHF vs CSWYF Comparison April 2026
CBDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBDHF stands at 1.6K. In comparison, CSWYF has a market cap of 758.4M. Regarding current trading prices, CBDHF is priced at $0.00, while CSWYF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBDHF currently has a P/E ratio of N/A, whereas CSWYF's P/E ratio is 4.78. In terms of profitability, CBDHF's ROE is +0.00%, compared to CSWYF's ROE of +0.20%. Regarding short-term risk, CBDHF is more volatile compared to CSWYF. This indicates potentially higher risk in terms of short-term price fluctuations for CBDHF.Check CSWYF's competition here
CBDHF vs TRXPF Comparison April 2026
CBDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBDHF stands at 1.6K. In comparison, TRXPF has a market cap of 690.7M. Regarding current trading prices, CBDHF is priced at $0.00, while TRXPF trades at $24.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBDHF currently has a P/E ratio of N/A, whereas TRXPF's P/E ratio is 25.86. In terms of profitability, CBDHF's ROE is +0.00%, compared to TRXPF's ROE of +0.04%. Regarding short-term risk, CBDHF is more volatile compared to TRXPF. This indicates potentially higher risk in terms of short-term price fluctuations for CBDHF.Check TRXPF's competition here
CBDHF vs SHEZF Comparison April 2026
CBDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBDHF stands at 1.6K. In comparison, SHEZF has a market cap of 690.3M. Regarding current trading prices, CBDHF is priced at $0.00, while SHEZF trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBDHF currently has a P/E ratio of N/A, whereas SHEZF's P/E ratio is -23.48. In terms of profitability, CBDHF's ROE is +0.00%, compared to SHEZF's ROE of +0.03%. Regarding short-term risk, CBDHF is more volatile compared to SHEZF. This indicates potentially higher risk in terms of short-term price fluctuations for CBDHF.Check SHEZF's competition here
CBDHF vs YIHCF Comparison April 2026
CBDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBDHF stands at 1.6K. In comparison, YIHCF has a market cap of 643.1M. Regarding current trading prices, CBDHF is priced at $0.00, while YIHCF trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBDHF currently has a P/E ratio of N/A, whereas YIHCF's P/E ratio is -5.00. In terms of profitability, CBDHF's ROE is +0.00%, compared to YIHCF's ROE of +0.06%. Regarding short-term risk, CBDHF is more volatile compared to YIHCF. This indicates potentially higher risk in terms of short-term price fluctuations for CBDHF.Check YIHCF's competition here
CBDHF vs GLASF Comparison April 2026
CBDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBDHF stands at 1.6K. In comparison, GLASF has a market cap of 639.5M. Regarding current trading prices, CBDHF is priced at $0.00, while GLASF trades at $8.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBDHF currently has a P/E ratio of N/A, whereas GLASF's P/E ratio is -15.02. In terms of profitability, CBDHF's ROE is +0.00%, compared to GLASF's ROE of -0.23%. Regarding short-term risk, CBDHF is more volatile compared to GLASF. This indicates potentially higher risk in terms of short-term price fluctuations for CBDHF.Check GLASF's competition here
CBDHF vs AIHLF Comparison April 2026
CBDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBDHF stands at 1.6K. In comparison, AIHLF has a market cap of 624.3M. Regarding current trading prices, CBDHF is priced at $0.00, while AIHLF trades at $3.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBDHF currently has a P/E ratio of N/A, whereas AIHLF's P/E ratio is 10.94. In terms of profitability, CBDHF's ROE is +0.00%, compared to AIHLF's ROE of +0.15%. Regarding short-term risk, CBDHF is more volatile compared to AIHLF. This indicates potentially higher risk in terms of short-term price fluctuations for CBDHF.Check AIHLF's competition here
CBDHF vs TRSSF Comparison April 2026
CBDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBDHF stands at 1.6K. In comparison, TRSSF has a market cap of 601.9M. Regarding current trading prices, CBDHF is priced at $0.00, while TRSSF trades at $1.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBDHF currently has a P/E ratio of N/A, whereas TRSSF's P/E ratio is -1.32. In terms of profitability, CBDHF's ROE is +0.00%, compared to TRSSF's ROE of -0.68%. Regarding short-term risk, CBDHF is more volatile compared to TRSSF. This indicates potentially higher risk in terms of short-term price fluctuations for CBDHF.Check TRSSF's competition here
CBDHF vs PKBFF Comparison April 2026
CBDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBDHF stands at 1.6K. In comparison, PKBFF has a market cap of 544.7M. Regarding current trading prices, CBDHF is priced at $0.00, while PKBFF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBDHF currently has a P/E ratio of N/A, whereas PKBFF's P/E ratio is N/A. In terms of profitability, CBDHF's ROE is +0.00%, compared to PKBFF's ROE of +7.96%. Regarding short-term risk, CBDHF is more volatile compared to PKBFF. This indicates potentially higher risk in terms of short-term price fluctuations for CBDHF.Check PKBFF's competition here
CBDHF vs KHTRF Comparison April 2026
CBDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBDHF stands at 1.6K. In comparison, KHTRF has a market cap of 521.5M. Regarding current trading prices, CBDHF is priced at $0.00, while KHTRF trades at $5.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBDHF currently has a P/E ratio of N/A, whereas KHTRF's P/E ratio is -133.00. In terms of profitability, CBDHF's ROE is +0.00%, compared to KHTRF's ROE of -0.01%. Regarding short-term risk, CBDHF is more volatile compared to KHTRF. This indicates potentially higher risk in terms of short-term price fluctuations for CBDHF.Check KHTRF's competition here
CBDHF vs CCHWF Comparison April 2026
CBDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBDHF stands at 1.6K. In comparison, CCHWF has a market cap of 521.3M. Regarding current trading prices, CBDHF is priced at $0.00, while CCHWF trades at $0.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBDHF currently has a P/E ratio of N/A, whereas CCHWF's P/E ratio is -1.12. In terms of profitability, CBDHF's ROE is +0.00%, compared to CCHWF's ROE of +0.42%. Regarding short-term risk, CBDHF is more volatile compared to CCHWF. This indicates potentially higher risk in terms of short-term price fluctuations for CBDHF.Check CCHWF's competition here
CBDHF vs BOIRF Comparison April 2026
CBDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBDHF stands at 1.6K. In comparison, BOIRF has a market cap of 520.9M. Regarding current trading prices, CBDHF is priced at $0.00, while BOIRF trades at $30.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBDHF currently has a P/E ratio of N/A, whereas BOIRF's P/E ratio is 22.73. In terms of profitability, CBDHF's ROE is +0.00%, compared to BOIRF's ROE of +0.05%. Regarding short-term risk, CBDHF is more volatile compared to BOIRF. This indicates potentially higher risk in terms of short-term price fluctuations for CBDHF.Check BOIRF's competition here
CBDHF vs AGYTF Comparison April 2026
CBDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBDHF stands at 1.6K. In comparison, AGYTF has a market cap of 504.6M. Regarding current trading prices, CBDHF is priced at $0.00, while AGYTF trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBDHF currently has a P/E ratio of N/A, whereas AGYTF's P/E ratio is -11.00. In terms of profitability, CBDHF's ROE is +0.00%, compared to AGYTF's ROE of +1.75%. Regarding short-term risk, CBDHF is more volatile compared to AGYTF. This indicates potentially higher risk in terms of short-term price fluctuations for CBDHF.Check AGYTF's competition here
CBDHF vs PEXXF Comparison April 2026
CBDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBDHF stands at 1.6K. In comparison, PEXXF has a market cap of 463.1M. Regarding current trading prices, CBDHF is priced at $0.00, while PEXXF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBDHF currently has a P/E ratio of N/A, whereas PEXXF's P/E ratio is 9.00. In terms of profitability, CBDHF's ROE is +0.00%, compared to PEXXF's ROE of N/A. Regarding short-term risk, CBDHF is more volatile compared to PEXXF. This indicates potentially higher risk in terms of short-term price fluctuations for CBDHF.Check PEXXF's competition here
CBDHF vs HUMDF Comparison April 2026
CBDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBDHF stands at 1.6K. In comparison, HUMDF has a market cap of 407.7M. Regarding current trading prices, CBDHF is priced at $0.00, while HUMDF trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBDHF currently has a P/E ratio of N/A, whereas HUMDF's P/E ratio is 2.58. In terms of profitability, CBDHF's ROE is +0.00%, compared to HUMDF's ROE of +1.07%. Regarding short-term risk, CBDHF is more volatile compared to HUMDF. This indicates potentially higher risk in terms of short-term price fluctuations for CBDHF.Check HUMDF's competition here
CBDHF vs SWDCF Comparison April 2026
CBDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBDHF stands at 1.6K. In comparison, SWDCF has a market cap of 399.6M. Regarding current trading prices, CBDHF is priced at $0.00, while SWDCF trades at $2.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBDHF currently has a P/E ratio of N/A, whereas SWDCF's P/E ratio is 62.50. In terms of profitability, CBDHF's ROE is +0.00%, compared to SWDCF's ROE of +0.01%. Regarding short-term risk, CBDHF is more volatile compared to SWDCF. This indicates potentially higher risk in terms of short-term price fluctuations for CBDHF.Check SWDCF's competition here
CBDHF vs NIKA Comparison April 2026
CBDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBDHF stands at 1.6K. In comparison, NIKA has a market cap of 395.1M. Regarding current trading prices, CBDHF is priced at $0.00, while NIKA trades at $0.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBDHF currently has a P/E ratio of N/A, whereas NIKA's P/E ratio is N/A. In terms of profitability, CBDHF's ROE is +0.00%, compared to NIKA's ROE of +0.29%. Regarding short-term risk, CBDHF is more volatile compared to NIKA. This indicates potentially higher risk in terms of short-term price fluctuations for CBDHF.Check NIKA's competition here
CBDHF vs ELTP Comparison April 2026
CBDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBDHF stands at 1.6K. In comparison, ELTP has a market cap of 390.3M. Regarding current trading prices, CBDHF is priced at $0.00, while ELTP trades at $0.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBDHF currently has a P/E ratio of N/A, whereas ELTP's P/E ratio is 9.06. In terms of profitability, CBDHF's ROE is +0.00%, compared to ELTP's ROE of +0.71%. Regarding short-term risk, CBDHF is more volatile compared to ELTP. This indicates potentially higher risk in terms of short-term price fluctuations for CBDHF.Check ELTP's competition here
CBDHF vs VRNOF Comparison April 2026
CBDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBDHF stands at 1.6K. In comparison, VRNOF has a market cap of 365.4M. Regarding current trading prices, CBDHF is priced at $0.00, while VRNOF trades at $1.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBDHF currently has a P/E ratio of N/A, whereas VRNOF's P/E ratio is -1.02. In terms of profitability, CBDHF's ROE is +0.00%, compared to VRNOF's ROE of -0.30%. Regarding short-term risk, CBDHF is more volatile compared to VRNOF. This indicates potentially higher risk in terms of short-term price fluctuations for CBDHF.Check VRNOF's competition here
CBDHF vs CPHRF Comparison April 2026
CBDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBDHF stands at 1.6K. In comparison, CPHRF has a market cap of 331.8M. Regarding current trading prices, CBDHF is priced at $0.00, while CPHRF trades at $13.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBDHF currently has a P/E ratio of N/A, whereas CPHRF's P/E ratio is 12.44. In terms of profitability, CBDHF's ROE is +0.00%, compared to CPHRF's ROE of +0.24%. Regarding short-term risk, CBDHF is more volatile compared to CPHRF. This indicates potentially higher risk in terms of short-term price fluctuations for CBDHF.Check CPHRF's competition here
CBDHF vs CRLBF Comparison April 2026
CBDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBDHF stands at 1.6K. In comparison, CRLBF has a market cap of 305.5M. Regarding current trading prices, CBDHF is priced at $0.00, while CRLBF trades at $0.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBDHF currently has a P/E ratio of N/A, whereas CRLBF's P/E ratio is -2.34. In terms of profitability, CBDHF's ROE is +0.00%, compared to CRLBF's ROE of -0.33%. Regarding short-term risk, CBDHF is more volatile compared to CRLBF. This indicates potentially higher risk in terms of short-term price fluctuations for CBDHF.Check CRLBF's competition here
CBDHF vs PROCF Comparison April 2026
CBDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBDHF stands at 1.6K. In comparison, PROCF has a market cap of 253.4M. Regarding current trading prices, CBDHF is priced at $0.00, while PROCF trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBDHF currently has a P/E ratio of N/A, whereas PROCF's P/E ratio is 0.27. In terms of profitability, CBDHF's ROE is +0.00%, compared to PROCF's ROE of -2.24%. Regarding short-term risk, CBDHF is less volatile compared to PROCF. This indicates potentially lower risk in terms of short-term price fluctuations for CBDHF.Check PROCF's competition here
CBDHF vs BHCCF Comparison April 2026
CBDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBDHF stands at 1.6K. In comparison, BHCCF has a market cap of 225.1M. Regarding current trading prices, CBDHF is priced at $0.00, while BHCCF trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBDHF currently has a P/E ratio of N/A, whereas BHCCF's P/E ratio is -4.57. In terms of profitability, CBDHF's ROE is +0.00%, compared to BHCCF's ROE of +0.29%. Regarding short-term risk, CBDHF is more volatile compared to BHCCF. This indicates potentially higher risk in terms of short-term price fluctuations for CBDHF.Check BHCCF's competition here
CBDHF vs PLNHF Comparison April 2026
CBDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBDHF stands at 1.6K. In comparison, PLNHF has a market cap of 202M. Regarding current trading prices, CBDHF is priced at $0.00, while PLNHF trades at $0.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBDHF currently has a P/E ratio of N/A, whereas PLNHF's P/E ratio is -3.50. In terms of profitability, CBDHF's ROE is +0.00%, compared to PLNHF's ROE of +659479.06%. Regarding short-term risk, CBDHF is more volatile compared to PLNHF. This indicates potentially higher risk in terms of short-term price fluctuations for CBDHF.Check PLNHF's competition here
CBDHF vs PHCUF Comparison April 2026
CBDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBDHF stands at 1.6K. In comparison, PHCUF has a market cap of 188.1M. Regarding current trading prices, CBDHF is priced at $0.00, while PHCUF trades at $7.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBDHF currently has a P/E ratio of N/A, whereas PHCUF's P/E ratio is -707.00. In terms of profitability, CBDHF's ROE is +0.00%, compared to PHCUF's ROE of -0.00%. Regarding short-term risk, CBDHF is more volatile compared to PHCUF. This indicates potentially higher risk in terms of short-term price fluctuations for CBDHF.Check PHCUF's competition here
CBDHF vs COPHF Comparison April 2026
CBDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBDHF stands at 1.6K. In comparison, COPHF has a market cap of 131.7M. Regarding current trading prices, CBDHF is priced at $0.00, while COPHF trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBDHF currently has a P/E ratio of N/A, whereas COPHF's P/E ratio is -0.02. In terms of profitability, CBDHF's ROE is +0.00%, compared to COPHF's ROE of -5.75%. Regarding short-term risk, CBDHF is less volatile compared to COPHF. This indicates potentially lower risk in terms of short-term price fluctuations for CBDHF.Check COPHF's competition here
CBDHF vs LOVFF Comparison April 2026
CBDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBDHF stands at 1.6K. In comparison, LOVFF has a market cap of 124.5M. Regarding current trading prices, CBDHF is priced at $0.00, while LOVFF trades at $1.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBDHF currently has a P/E ratio of N/A, whereas LOVFF's P/E ratio is 14.44. In terms of profitability, CBDHF's ROE is +0.00%, compared to LOVFF's ROE of +0.12%. Regarding short-term risk, CBDHF is more volatile compared to LOVFF. This indicates potentially higher risk in terms of short-term price fluctuations for CBDHF.Check LOVFF's competition here
CBDHF vs NWPN Comparison April 2026
CBDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBDHF stands at 1.6K. In comparison, NWPN has a market cap of 123.7M. Regarding current trading prices, CBDHF is priced at $0.00, while NWPN trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBDHF currently has a P/E ratio of N/A, whereas NWPN's P/E ratio is -0.04. In terms of profitability, CBDHF's ROE is +0.00%, compared to NWPN's ROE of +0.13%. Regarding short-term risk, CBDHF is less volatile compared to NWPN. This indicates potentially lower risk in terms of short-term price fluctuations for CBDHF.Check NWPN's competition here
CBDHF vs CBWTF Comparison April 2026
CBDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBDHF stands at 1.6K. In comparison, CBWTF has a market cap of 121.4M. Regarding current trading prices, CBDHF is priced at $0.00, while CBWTF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBDHF currently has a P/E ratio of N/A, whereas CBWTF's P/E ratio is 4.50. In terms of profitability, CBDHF's ROE is +0.00%, compared to CBWTF's ROE of +0.27%. Regarding short-term risk, CBDHF is more volatile compared to CBWTF. This indicates potentially higher risk in terms of short-term price fluctuations for CBDHF.Check CBWTF's competition here
CBDHF vs BIOYF Comparison April 2026
CBDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBDHF stands at 1.6K. In comparison, BIOYF has a market cap of 118.5M. Regarding current trading prices, CBDHF is priced at $0.00, while BIOYF trades at $10.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBDHF currently has a P/E ratio of N/A, whereas BIOYF's P/E ratio is 18.40. In terms of profitability, CBDHF's ROE is +0.00%, compared to BIOYF's ROE of +0.23%. Regarding short-term risk, CBDHF is more volatile compared to BIOYF. This indicates potentially higher risk in terms of short-term price fluctuations for CBDHF.Check BIOYF's competition here
CBDHF vs CWBHF Comparison April 2026
CBDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBDHF stands at 1.6K. In comparison, CWBHF has a market cap of 117.2M. Regarding current trading prices, CBDHF is priced at $0.00, while CWBHF trades at $0.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBDHF currently has a P/E ratio of N/A, whereas CWBHF's P/E ratio is -5.25. In terms of profitability, CBDHF's ROE is +0.00%, compared to CWBHF's ROE of -2.75%. Regarding short-term risk, CBDHF is more volatile compared to CWBHF. This indicates potentially higher risk in terms of short-term price fluctuations for CBDHF.Check CWBHF's competition here
CBDHF vs SHIEF Comparison April 2026
CBDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBDHF stands at 1.6K. In comparison, SHIEF has a market cap of 114.7M. Regarding current trading prices, CBDHF is priced at $0.00, while SHIEF trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBDHF currently has a P/E ratio of N/A, whereas SHIEF's P/E ratio is -5.37. In terms of profitability, CBDHF's ROE is +0.00%, compared to SHIEF's ROE of +1.40%. Regarding short-term risk, CBDHF is more volatile compared to SHIEF. This indicates potentially higher risk in terms of short-term price fluctuations for CBDHF.Check SHIEF's competition here
CBDHF vs LPCUF Comparison April 2026
CBDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBDHF stands at 1.6K. In comparison, LPCUF has a market cap of 112.1M. Regarding current trading prices, CBDHF is priced at $0.00, while LPCUF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBDHF currently has a P/E ratio of N/A, whereas LPCUF's P/E ratio is 9.51. In terms of profitability, CBDHF's ROE is +0.00%, compared to LPCUF's ROE of +0.04%. Regarding short-term risk, CBDHF is more volatile compared to LPCUF. This indicates potentially higher risk in terms of short-term price fluctuations for CBDHF.Check LPCUF's competition here
CBDHF vs CNVCF Comparison April 2026
CBDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBDHF stands at 1.6K. In comparison, CNVCF has a market cap of 109.2M. Regarding current trading prices, CBDHF is priced at $0.00, while CNVCF trades at $6.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBDHF currently has a P/E ratio of N/A, whereas CNVCF's P/E ratio is -5.00. In terms of profitability, CBDHF's ROE is +0.00%, compared to CNVCF's ROE of +1.21%. Regarding short-term risk, CBDHF is more volatile compared to CNVCF. This indicates potentially higher risk in terms of short-term price fluctuations for CBDHF.Check CNVCF's competition here
CBDHF vs JUSHF Comparison April 2026
CBDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBDHF stands at 1.6K. In comparison, JUSHF has a market cap of 102.8M. Regarding current trading prices, CBDHF is priced at $0.00, while JUSHF trades at $0.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBDHF currently has a P/E ratio of N/A, whereas JUSHF's P/E ratio is -1.58. In terms of profitability, CBDHF's ROE is +0.00%, compared to JUSHF's ROE of +0.89%. Regarding short-term risk, CBDHF is more volatile compared to JUSHF. This indicates potentially higher risk in terms of short-term price fluctuations for CBDHF.Check JUSHF's competition here
CBDHF vs ORXOY Comparison April 2026
CBDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBDHF stands at 1.6K. In comparison, ORXOY has a market cap of 97.2M. Regarding current trading prices, CBDHF is priced at $0.00, while ORXOY trades at $2.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBDHF currently has a P/E ratio of N/A, whereas ORXOY's P/E ratio is -2.26. In terms of profitability, CBDHF's ROE is +0.00%, compared to ORXOY's ROE of +5.65%. Regarding short-term risk, CBDHF is more volatile compared to ORXOY. This indicates potentially higher risk in terms of short-term price fluctuations for CBDHF.Check ORXOY's competition here
CBDHF vs AAWH Comparison April 2026
CBDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBDHF stands at 1.6K. In comparison, AAWH has a market cap of 97.1M. Regarding current trading prices, CBDHF is priced at $0.00, while AAWH trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBDHF currently has a P/E ratio of N/A, whereas AAWH's P/E ratio is -0.83. In terms of profitability, CBDHF's ROE is +0.00%, compared to AAWH's ROE of -14.10%. Regarding short-term risk, CBDHF is more volatile compared to AAWH. This indicates potentially higher risk in terms of short-term price fluctuations for CBDHF.Check AAWH's competition here
CBDHF vs ABSCF Comparison April 2026
CBDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBDHF stands at 1.6K. In comparison, ABSCF has a market cap of 96M. Regarding current trading prices, CBDHF is priced at $0.00, while ABSCF trades at $1.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBDHF currently has a P/E ratio of N/A, whereas ABSCF's P/E ratio is -8.53. In terms of profitability, CBDHF's ROE is +0.00%, compared to ABSCF's ROE of +0.33%. Regarding short-term risk, CBDHF is more volatile compared to ABSCF. This indicates potentially higher risk in terms of short-term price fluctuations for CBDHF.Check ABSCF's competition here
CBDHF vs HLTRF Comparison April 2026
CBDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBDHF stands at 1.6K. In comparison, HLTRF has a market cap of 93.8M. Regarding current trading prices, CBDHF is priced at $0.00, while HLTRF trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBDHF currently has a P/E ratio of N/A, whereas HLTRF's P/E ratio is -7.69. In terms of profitability, CBDHF's ROE is +0.00%, compared to HLTRF's ROE of -0.19%. Regarding short-term risk, CBDHF is more volatile compared to HLTRF. This indicates potentially higher risk in terms of short-term price fluctuations for CBDHF.Check HLTRF's competition here
CBDHF vs ORXOF Comparison April 2026
CBDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBDHF stands at 1.6K. In comparison, ORXOF has a market cap of 79.3M. Regarding current trading prices, CBDHF is priced at $0.00, while ORXOF trades at $2.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBDHF currently has a P/E ratio of N/A, whereas ORXOF's P/E ratio is -1.84. In terms of profitability, CBDHF's ROE is +0.00%, compared to ORXOF's ROE of +5.65%. Regarding short-term risk, CBDHF is more volatile compared to ORXOF. This indicates potentially higher risk in terms of short-term price fluctuations for CBDHF.Check ORXOF's competition here
CBDHF vs EOFBY Comparison April 2026
CBDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBDHF stands at 1.6K. In comparison, EOFBY has a market cap of 73.7M. Regarding current trading prices, CBDHF is priced at $0.00, while EOFBY trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBDHF currently has a P/E ratio of N/A, whereas EOFBY's P/E ratio is -7.67. In terms of profitability, CBDHF's ROE is +0.00%, compared to EOFBY's ROE of -0.77%. Regarding short-term risk, CBDHF is more volatile compared to EOFBY. This indicates potentially higher risk in terms of short-term price fluctuations for CBDHF.Check EOFBY's competition here
CBDHF vs GRUSF Comparison April 2026
CBDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBDHF stands at 1.6K. In comparison, GRUSF has a market cap of 73.6M. Regarding current trading prices, CBDHF is priced at $0.00, while GRUSF trades at $0.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBDHF currently has a P/E ratio of N/A, whereas GRUSF's P/E ratio is 9.83. In terms of profitability, CBDHF's ROE is +0.00%, compared to GRUSF's ROE of +0.28%. Regarding short-term risk, CBDHF is more volatile compared to GRUSF. This indicates potentially higher risk in terms of short-term price fluctuations for CBDHF.Check GRUSF's competition here
CBDHF vs MEDXF Comparison April 2026
CBDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBDHF stands at 1.6K. In comparison, MEDXF has a market cap of 72.4M. Regarding current trading prices, CBDHF is priced at $0.00, while MEDXF trades at $2.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBDHF currently has a P/E ratio of N/A, whereas MEDXF's P/E ratio is -112.00. In terms of profitability, CBDHF's ROE is +0.00%, compared to MEDXF's ROE of -0.01%. Regarding short-term risk, CBDHF is more volatile compared to MEDXF. This indicates potentially higher risk in terms of short-term price fluctuations for CBDHF.Check MEDXF's competition here